Overcoming Clinical Inertia in the Treatment of Hypertension
- PMID: 38866526
- DOI: 10.2169/internalmedicine.3747-24
Overcoming Clinical Inertia in the Treatment of Hypertension
Abstract
Objective This study aimed to investigate the antihypertensive goal achievement rate for office blood pressure (OBP) and the rate of clinical inertia (inertia) as factors for non-achievement in hypertensive patients in 2020. After documenting these results in the medical records, we observed changes in the achievement rate of the OBP goals in 2020 and 2022. Methods In Study 1, the participants were 517 outpatients (mean age 68.6±13.2 years, 54% women) who visited the Division of Hypertension regularly between March and September 2020. We investigated the achievement rate of OBP goals during that period and confirmed the prevalence of inertia as a possible factor for failure to achieve OBP goals. In Study 2, the participants were 308 who visited the division, and who had at least one condition for which an OBP of <130/80 should be targeted in both 2020 and 2022 (mean age 66.6±12.4 years, 50% of women in 2020). We investigated the trends in the achievement of OBP for the same period in both years. Results The rate of achievement of the OBP goals in 2020 was 48%. Inertia accounted for 14% of the non-achievement factors. The OBP significantly decreased in 2022 in comparison to 2020. The achievement rate of OBP goals showed an increasing trend from 45% in 2020 to 52% in 2022. Conclusion Attending physicians' awareness of unmet antihypertensive goals can help them overcome inertia and improve blood pressure control in patients.
Keywords: Antihypertensive goals; Blood pressure; Clinical inertia; Hypertension.
Similar articles
-
Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial.JAMA Netw Open. 2022 Jan 4;5(1):e2143001. doi: 10.1001/jamanetworkopen.2021.43001. JAMA Netw Open. 2022. PMID: 35006243 Free PMC article. Clinical Trial.
-
Improving the Management of Hypertension by Tackling Awareness, Adherence, and Clinical Inertia: A Symposium Report.Am J Cardiovasc Drugs. 2022 May;22(3):251-261. doi: 10.1007/s40256-021-00505-6. Epub 2021 Nov 9. Am J Cardiovasc Drugs. 2022. PMID: 34751917 Free PMC article. Review.
-
Effect of guideline revisions by the Swiss Society of Hypertension on blood pressure control in hypertensive patients from primary care.Swiss Med Wkly. 2020 Jun 29;150:w20279. doi: 10.4414/smw.2020.20279. eCollection 2020 Jun 28. Swiss Med Wkly. 2020. PMID: 32657419
-
Automated office blood pressure measurements in primary care are misleading in more than one third of treated hypertensives: The VALENTINE-Greece Home Blood Pressure Monitoring study.Hellenic J Cardiol. 2020 May-Jun;61(3):174-177. doi: 10.1016/j.hjc.2019.01.005. Epub 2019 Jan 9. Hellenic J Cardiol. 2020. PMID: 30639355
-
Therapeutic Inertia and Treatment Intensification.Curr Hypertens Rep. 2018 Jan 29;20(1):4. doi: 10.1007/s11906-018-0802-1. Curr Hypertens Rep. 2018. PMID: 29380142 Free PMC article. Review.
LinkOut - more resources
Full Text Sources